The DOI matches its Crossref record; 45 of the 48 references it cites were found in a registry or an index.
Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia
Open accessAbstract
21-Hydroxylase deficiency which causes congenital adrenal hyperplasia is one of the most common defects of adrenal steroidogenesis. There are two 21-hydroxylase genes in man, A and B, and these have been mapped to the HLA class III region. Only the 21-hydroxylase B gene is thought to be active. To understand the molecular basis of congenital adrenal hyperplasia in a patient with the salt-wasting form of the disease, we cloned and characterized his single 21-hydroxylase B gene. The nucleotide sequence of this gene and a 21-hydroxylase B gene from a normal individual have been determined. Comparison of the two sequences has revealed 11 nucleotide alterations, of which two are in the 5' flanking region, four are in introns, one is in the 3' untranslated region and four are in exons. Two of the differences in exons cause codon changes, with Ser-269 and Asn-494 in the normal 21-hydroxylase B gene being converted to Thr and Ser, respectively. These amino acid substitutions may give an insight into those residues necessary for 21-hydroxylase enzymatic activity. We have also confirmed that the 21-hydroxylase A gene is a pseudogene due to three deleterious mutations in the exons. In addition, comparison of the 21-hydroxylase B gene sequence with other published sequences indicates that this microsomal cytochrome P-450 may be polymorphic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The CYP21 genes consist of 10 exons (373), are about 3.4 kb long, and differ in only 87 or 88 of these bases (357-359).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [359]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, characterization of the P450c21 protein (355) and gene cloning show there is only one 21-hydroxylase encoded by a single functional gene on chromosome 6p21 (356 -359).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [359]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,245
Molecular Cloning. A Laboratory Manual
Wood, E. (1983) · Biochemical Education · doi:10.1016/0307-4412(83)90068-7 · Cited by 29,534
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
A rapid alkaline extraction procedure for screening recombinant plasmid DNA
Birnboim, H. C., & Doly, J. (1979) · Nucleic Acids Research · doi:10.1093/nar/7.6.1513 · Cited by 14,686
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 13,943
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. R. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,400
Wahl, G. M., Stern, M., & Stark, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3683 · Cited by 3,159
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments
Messing, J. W., & Vieira, J. (1982) · Gene · doi:10.1016/0378-1119(82)90016-6 · Cited by 2,833
Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination.
Biggin, M. D., Gibson, T. J., & Hong, G. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.13.3963 · Cited by 2,320
Research works printed but not linked: 18
- [2]2. Bell,G.I., Karam,J.H. and Rutter,W.J. (1981) Proc. Natl. Acad. Sci. USA, 78, 5759-5763.
- [5]5. Biggin,M.D., Gibson,T.J. and Hong,G.F. (1983) Proc. Natl. Acad. Sci. USA, 80, 3963-3965.
- [7]7. Carroll,M.C., Belt,K.T., Palsdottir,A. and Porter,R.R. (1984a) Phil. Trans. Soc. Lond., B., 306, 379-388.
- [9]9. Carroll,M.C., Campbell,R.D. and Porter,R.R. (1985a) Proc. Natl. Acad. Sci. USA, 82, 521-525.
- [11]11. Chaplin,D.D., Galbraith,L.J., Seidman,J.G., White,P.C. and Parker,K.L. (1986) Proc. Natl. Acad. Sci. USA, 83, 9601-9605.
- [12]12. Chung,B., Matteson,K.J. and Miller,W.L. (1985) Proc. Natl. Acad. Sci. USA, 83, 4243-4247.
- [16]16. Dupont,B., Pollack,M.S., Levine,L.S., O'Neill,G.J., Hawkins,B.R. and New, M.I. (1980) In Terasaki,P.I. (ed.), Histocompatibility Testing. UCLA Press, pp. 693-706.
- [20]20. Giles,C.M. (1987) Human Immunol., in press.
- [23]23. Higashi,Y., Yoshioka,H., Yamane,M., Gotoh,O. and Fujii-Kuriyama,Y. (1986) Proc. Natl. Acad. Sci. USA, 83, 2841-2845.
- [28]28. Morohashi,K., Fujii-Kuriyama,Y., Okada,Y., Sogawa,K., Hirose,T., Inayama,S. and Omura,T. (1984) Proc. Natl. Acad. Sci. USA, 81, 4647-4651.
- [30]30. New,M.I., Dupont,B., Grumback,K. and Levine,L.S. (1982) In Stanbury,J.B., Wyngarden,J.B., Fredrickson,D.S., Goldstein,J.L. and Brown,M.S. (eds), Metabolic Basis of Inherited Disease. McGraw-Hill, New York, pp. 973- 1000. 14602075, 1987, 6, Downloaded from https://www.embopress.org/doi/10.1002/j.1460-2075.1987.tb02414.x by Readcube (Labtiva Inc.), Wiley Online Library on [14/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
- [36]36. Sanger,F., Nicklen,S. and Coulson,A.R. (1977) Proc. Natl. Acad. Sci. USA, 74, 5463-5468.
- [40]40. Wahl,G.M., Stern,M. and Stark,G.R. (1979) Proc. Natl. Acad. Sci. USA, 76, 3686-3687.
- [42]42. White,P.C., New,M.I. and Dupont,B. (1984a) Proc. Natl. Acad. Sci. USA, 81, 7505-7509.
- [43]43. White,P.C., New,M.I. and Dupont,B. (1984b) Proc. Natl. Acad. Sci. USA, 81, 1986-1990.
- [44]44. White,P.C., Grossberg,D., Onufer,B.J., Chaplin,D.D. and New,M.I. (1985) Proc. Natl. Acad. Sci. USA, 82, 1089-1093.
- [45]45. White,P.C., New,M.I. and Dupont,B. (1986) Proc. Natl. Acad. Sci. USA, 83, 5111-5115.
- [47]47. Yu,C.Y. and Campbell,R.D. (1987) Immunogenetics, in press.
Cited by
Sorted by citations
Items 101–182 of 182
Organization of the chimpanzee C4‐CYP21 region: Implications for the evolution of human genes
Kawaguchi, H., Golubić, M., Figueroa, F., & Klein, J. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200405 · Cited by 18
Genetic defects of the CYP21A2 gene in girls with premature adrenarche
Skordis, N., Shammas, C., Phedonos, A., Kyriakou, A., Toumba, M., Neocleous, V., & Phylactou, L. A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0223-1 · Cited by 17
“Asn493Ser substitution [32].”
CYP21/C4 gene organisation in Italian 21-hydroxylase deficiency families
Sinnott, P. J., Livieri, C., Sampietro, M., Marconi, M., Harris, R., Severi, F., & Strachan, T. (1992) · Human Genetics · doi:10.1007/bf00219342 · Cited by 17
“Subsequent molecular genetic analyses have located the normally functional 21-OH gene (CYP21B) and a highly homologous pseudogene (CYP21A) in the class III region of the H L A complex (White et al. 1985; Higashi et al. 1986; Rodrigues et al. 1987).”
BackgroundCYP21A2 intronic variants causing 21-hydroxylase deficiency
Concolino, P., Rizza, R., Costella, A., Carrozza, C., Zuppi, C., & Capoluongo, E. (2017) · Metabolism · doi:10.1016/j.metabol.2017.03.003 · Cited by 16
Neocleous, V., Fanis, P., Phylactou, L. A., & Skordis, N. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00733 · Cited by 16
Polymorphism of C4 and CYP21 genes in various primate species
Bontrop, R. E., Broos, L. A. M., Otting, N., Jonker, M. J., & Bontrop, R. E. (1991) · Tissue Antigens · doi:10.1111/j.1399-0039.1991.tb01862.x · Cited by 16
Molecular pathology of steroid 21-hydroxylase deficiency
Strachan, T., & White, P. C. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90274-9 · Cited by 16
Extended MHC haplotypes and CYP21/C4 gene organisation in Irish 21-hydroxylase deficiency families
Sinnott, P. J., Costigan, C., Dyer, P. A., Harris, R., & Strachan, T. (1991) · Human Genetics · doi:10.1007/bf00200920 · Cited by 16
“Subsequent molecular genetic analyses have located the normally functional 21-hydroxylase gene CYP21B and a highly homologous pseudogene CYP21A in the class III region of the HLA complex (White et al. 1985; Higashi et al. 1986; Rodrigues et al. 1987).”
BackgroundDundar, A., Bayramov, R., Önal, M. G., Akkus, M., Doğan, M. E., Kenanoğlu, S., Güneş, M. C., Kazimli, U., Özbek, M. N., Ercan, O., et al. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04809-4 · Cited by 15
Wedell, A. (1996) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30291-9 · Cited by 15
Comprehensive Genetic Analysis and Structural Characterization of CYP21A2 Mutations in CAH Patients
Carvalho, B., Pereira, M., Marques, C. J., Carvalho, D. M., Leão, M., Oliveira, J. P., Barros, A., & Carvalho, F. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1323805 · Cited by 14
Baradaran‐Heravi, A., Vakili, R., Robins, T., Carlsson, J., Ghaemi, N., Arabi, A., & Abbaszadegan, M. R. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02886.x · Cited by 14
Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia
Neocleous, V., Ioannou, Y. S., Bartsota, M., Costi, C., Skordis, N., & Phylactou, L. A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.015 · Cited by 14
“In the same patient the normal variant S268T was also present in homozygosity and which in previous studies was reported not to be associated with CAH [21,22].”
ResultBrønstad, I., Breivik, L., Methlie, P., Wolff, A. S. B., Bratland, E., Nermoen, I., Løvås, K., & Husebye, E. S. (2014) · Endocrine Connections · doi:10.1530/ec-14-0032 · Cited by 15
Killeen, A. A., Jiddou, R. R., & Sane, K. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2410 · Cited by 14
Donohoue, P. A., Guethlein, L. A., Collins, M. M., Dop, C. V., Migeon, C. J., Bias, W. Β., & Schmeckpeper, B. J. (1995) · Tissue Antigens · doi:10.1111/j.1399-0039.1995.tb03115.x · Cited by 13
Organization of C4 and CYP21 loci in gorilla and orangutan
Kawaguchi, H., & Klein, J. (1992) · Human Immunology · doi:10.1016/0198-8859(92)90067-w · Cited by 13
Molecular Genetics of the Class III Region of the HLA Complex
White, P. C. (1989) · Springer eBooks · doi:10.1007/978-3-662-39946-0_6 · Cited by 13
3 The molecular genetics of components of the complement system
Campbell, R. D. (1988) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(88)80028-1 · Cited by 13
Self-citationHeterogeneity in the gene locus for steroid 21-hydroxylase deficiency.
Rumsby, G., Fielder, A. H. L., Hague, W. M., & Honour, J. W. (1988) · Journal of Medical Genetics · doi:10.1136/jmg.25.9.596 · Cited by 13
Characterization of Mutations Causing CYP21A2 Deficiency in Brazilian and Portuguese Populations
Prado, M. J., Singh, S., Ligabue‐Braun, R., Meneghetti, B. V., Rispoli, T., Kopacek, C., Monteiro, K. M., Zaha, A., Rossetti, M. L. R., & Pandey, A. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010296 · Cited by 12
“These genes share 98% sequence identity for the exons and 96% among the introns [18].”
BackgroundVariant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2
Prado, M. J., Ligabue‐Braun, R., Zaha, A., Rossetti, M. L. R., & Pandey, A. V. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.931089 · Cited by 9
“The CYP21A2 gene is a tandemly arranged module (RCCX: RP-C4-CYP21-TNX) and shows 96-98% of sequence identity with its pseudogene, CYP21A1P 5.”
BackgroundInfluentialHaglund-Stengler, B., Ritzén, E. M., & Luthman, H. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-1-43 · Cited by 11
Structure and organization of complement genes
Reid, K. B. M., & Campbell, R. D. (1993) · Springer eBooks · doi:10.1007/978-94-011-2214-6_3 · Cited by 11
Self-citationConcolino, P., Satta, M. A., Santonocito, C., Carrozza, C., Rocchetti, S., Ameglio, F., Giardina, E., Zuppi, C., & Capoluongo, E. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.07.020 · Cited by 10
Molecular genetics of congenital adrenal hyperplasia
Strachan, T. (1989) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(89)90005-2 · Cited by 10
Neocleous, V., Fanis, P., Toumba, M., Stylianou, C., Picolos, M. K., Andreou, E., Kyriakou, A., Iasonides, M., Nicolaou, S. A., Kyriakides, T. C., et al. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0957-3297 · Cited by 9
“The IVS2–13A/C > G splice site mutation is also known to result in an enzyme with minimal residual activity [27, 28].”
BackgroundŠáhó, R., Dolžan, V., Tanšek, M. Ž., Pastorakova, A., Petrovič, R., Knapková, M., Podkrajšek, K. T., Omladič, J. Š., Bertok, S., Stefanija, M. A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1134133 · Cited by 10
“also reported a patient in whom the hemizygous Asn493Ser pathogenic variant was combined with the S268T pathogenic variant (18).”
BackgroundStrumberg, D., Hauffa, B. P., Horsthemke, B., & Grosse‐Wilde, H. (1992) · European Journal of Pediatrics · doi:10.1007/bf01957933 · Cited by 9
“The P450C21A pseudogene has an 8-basepair deletion, which causes a frame shift and a point mutation, which creates a stop codon [14, 30, 36].”
BackgroundMTM1 mutations in X-linked myotubular myopathy
Laporte, J., Biancalana, V., Tanner, S. M., Kreß, W., Schneider, V., Wallgren‐Pettersson, C., Herger, F., Buj‐Bello, A., Blondeau, F., Liechti‐Gallati, S., et al. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200005)15:5 · Cited by 246
Genome editing in the adrenal gland: a novel strategy for treating congenital adrenal hyperplasia
van Dijk, E. B., Ginn, S. L., Alexander, I. E., & Graves, L. E. (2024) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2024.00011 · Cited by 8
BRADLEY, J., BAKER, D., DAVIDSCHWARTZ, I., & Rothberg, P. G. (1998) · Molecular Diagnosis · doi:10.1016/s1084-8592(98)80060-x · Cited by 7
Analysis of the duplicated human C4/P450c21/X gene cluster
Miller, W. L., Gitelman, S. E., Bristow, J. D., & Morel, Y. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90324-c · Cited by 7
Olerup, O., Luthman, H., Ritzén, E. M., & Haglund-Stengler, B. (1990) · Human Genetics · doi:10.1007/bf00194218 · Cited by 7
Collier, S., Tassabehji, M., & Strachan, T. (1992) · Genome Research · doi:10.1101/gr.1.3.181 · Cited by 7
Blaskó, B., Bánlaki, Z., Gyapay, G., Pozsonyi, É., Sasvári‐Székely, M., Rajczy, K., Füst, G., & Szilágyi, Á. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.033 · Cited by 6
Genetic analysis of the steroid 21-hydroxylase gene following in vitro amplification of genomic DNA
Rumsby, G., Skinner, C., & Honour, J. W. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90432-i · Cited by 6
Familial growth hormone deficiency associated with MRI abnormalities
Hamilton, J. K., Chitayat, D. A., Blasér, S., Cohen, L. E., Phillips, J. A., & Daneman, D. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19981102)80:2 · Cited by 57
Ghanem, N., Lobaccaro, J. A., Burési, C., Abbal, M., Halaby, G., Sultan, C., & Lefranc, G. (1990) · Human Genetics · doi:10.1007/bf00197691 · Cited by 6
“Although both C4-encoding genes are functional, the CYP21A gene is inactive because of at least three deleterious mutations in the coding sequence (Higashi et al. 1986; White et al. 1986; Rodrigues et al. 1987).”
BackgroundCongenital absence of lacrimal puncta and salivary glands: Report of a Brazilian family and review
Ferreira, A. P. S. D. S., Gomez, R. S., Castro, W. H., Calixto, N., Silva, R. A. P., & de Aguiar, M. J. B. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000904)94:1 · Cited by 44
Gaffney, D., Howie, A. F., Bakkush, A. M. E., Hoffmann, T. M., Mason, J. I., Wallace, A. M., & Donaldson, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.013 · Cited by 5
El‐Mougy, F., Sharaf, S. A. E.-A., Hafez, M. M., Khattab, A., Abou‐Youssef, H. S., Elsharkawy, M., Baz, H., Ekladious, S., Fahmy, B. S., Musa, N., et al. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13540 · Cited by 5
Clinical and Genetic Characterization of Nonclassic 21-hydroxylase Deficiency
Speiser, P., New, M. I., & White, P. C. (1989) · Endocrine Research · doi:10.1080/07435808909039100 · Cited by 5
Witchel, S. F., & Lee, P. A. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50009-0 · Cited by 4
Molecular Analysis of a Family With Congenital Adrenal Hyperplasia - Genotype/Phenotype Discrepancy
Anastasovska, V., & Kočova, M. (2007) · Balkan Journal of Medical Genetics · doi:10.2478/v10034-008-0003-3 · Cited by 3
“To distinguish between the inactive pseudogene (CYP21P) and the active gene (CYP21), two pairs of oli gonucleotide primers (21AF/AR and 21BF/BR, respectively) were used for differential amplification of these genes as previously described [17].”
BackgroundInfluentialCongenital Adrenal Hyperplasia: Experience in Iranian Patients
Azar, M. R., Nourbakhsh, M., & Nourbakhsh, M. (2012) · Journal of Comprehensive Pediatrics · doi:10.17795/compreped-5244 · Cited by 2
Travitz, J., & Metzger, D. L. (1999) · Genetics in Medicine · doi:10.1097/00125817-199907000-00010 · Cited by 3
A rare neutral polymorphism in 21-hydroxylase genes as HLA haplotype marker
Narko, K., Levo, A., & Partanen, J. (1995) · Human Immunology · doi:10.1016/0198-8859(94)00116-8 · Cited by 3
Lee, Y., Park, E., Kang, S., Kim, H., Lee, J. Y., & Lee, J. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01090.x · Cited by 3
“The polymorphic sequences of MspI, Fnu4HI and SmaI RFLPs are also present in the pseudogene (Higashi et al., 1986; White et al., 1986; Rodrigues et al., 1987), and are thought to be induced from CYP21P to CYP21 by gene conversion.”
BackgroundPartanen, J. (1987) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1987.tb00393.x · Cited by 3
Wells, G., & Azziz, R. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53939-9 · Cited by 3
Martinez-Arguelles, D. B., & Papadopoulos, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66177-9 · Cited by 3
Congenital adrenal hyperplasia in adults
Lin‐Su, K., Nimkarn, S., & New, M. I. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.1.67 · Cited by 2
Impact of Genome Complexity of the CYP21A2 Gene on Adrenal Steroidogenesis
Chang, S. (2012) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2012.10.005 · Cited by 2
Polat, S., Karaburgu, S., Unluhizarci, K., Dündar, M., Özkul, Y., Arslan, Y. K., Karaca, Z., & Keleştimur, F. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02093-5 · Cited by 3
“InsL9_10, R102K, S268T and S493N were variants of CYP21A2 with no negative effect on protein function [25]; the other variants, A159T, V211M and A265S, were unidentified in our research group [26, 27].”
BackgroundRelevance of Pseudogenes to Human Genetic Disease
Sen, K. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0025002 · Cited by 2
Partanen, J., & Campbell, R. D. (1991) · Human Genetics · doi:10.1007/bf00201731 · Cited by 2
“1kb in size and are split into ten exons (White et al. 1986; Higashi et al. 1986; Rodrigues et al. 1987).”
BackgroundSelf-citationIntegrated mapping resolves pathogenicity of 11 CYP21A2 variants in congenital adrenal hyperplasia
Xu, Y., Matveeva, A., Jørgensen, F. S., & Pandey, A. V. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag127 · Cited by 1
“3, in close proximity to a nonfunctional pseudogene, CYP21A1P , with which it shares 98% sequence homology in exons [18].”
Passarge, E. (1988) · The Indian Journal of Pediatrics · doi:10.1007/bf02868427 · Cited by 1
Menassa, R. (2009) · theses.fr (ABES) · doi:10.70675/b3e39fd0z238az4865z8447z7bdf24b846fb · Cited by 1
“Le CYP21 est codé par un seul gène CYP21A2 sur le chromosome 6p21 (Higashi et al., 1986),(Rodrigues et al., 1987), (White et al., 1986) .”
BackgroundOgo, A., Haji, M., Yanase, T., Kato, K., & Nawata, H. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03347937 · Cited by 1
Haji, M., Ogo, A., Ōhashi, M., Sekiya, K., Takayanagi, R., TAKAYAMA, K., Kumazawa, J., & Nawata, H. (1990) · Endocrinologia Japonica · doi:10.1507/endocrj1954.37.841 · Cited by 1
Molecular Genetics of Steroid 21-Hydroxylase Deficiency
New, M. I., & Crawford, C. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-728960-1.50021-5 · Cited by 1
Prado, M. J., Ligabue‐Braun, R., Zaha, A., Rossetti, M. L. R., & Pandey, A. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.21.473700 · Cited by 1
The Adrenal Cortex and its Disorders
Miller, W. L. (2005) · Clinical Pediatric Endocrinology · doi:10.1002/9780470987117.ch15 · Cited by 2
The Primate Class Ill MHC Region Encoding Complement Components and Other Genes
Figueroa, F. (1997) · Springer eBooks · doi:10.1007/978-3-642-59086-3_19 · Cited by 1
Gomes, L. G. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-09122009-152831
Polymorphic Bgl II restriction sites of DR? demarcate a novel HLA-DR1 antigen
Davis, J. E., Cook, R. G., Vane, M., & Rich, R. R. (1988) · Immunogenetics · doi:10.1007/bf00375856
Rothberg, P. G., Baker, D. W., & BRADLEY, J. F. (1998) · Genetic Testing · doi:10.1089/gte.1998.2.343
“The primer sequences were also checked against accession numbers M26856 (Rodrigues et al, 1987) and M12792 (Higashi et al, 1986).”
The Clinical Characteristics of Congenital Adrenal Hyperplasia
Park, S. J., Seo, J. Y., Kim, C. J., & Woo, Y. J. (2009) · Chonnam Medical Journal · doi:10.4068/cmj.2009.45.2.105
Chung, E. K. (2003) · OhioLink ETD Center (Ohio Library and Information Network)
Genetic Disorders of the Adrenal Gland
Lin‐Su, K., Lekarev, O., & New, M. I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00091-4
Analise molecular do loco C4/CYP21
Coeli, F. B. (2009) · doi:10.47749/t/unicamp.2009.440022
Merryweather‐Clarke, A. T., Siimonsen, H., Shearman, J. R., Pointon, J. J., N�rgaard-Pedersen, B., & Robson, K. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:2 · Cited by 53
Congenital Adrenal Hyperplasia: Experience in Iranian Patients
Azar, M. R., Nourbakhsh, M., & Nourbakhsh, M. (2012) · Journal of Comprehensive Pediatrics · doi:10.5812/jcp.5244
Mungall, A. J. J., & Dunham, I. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0775
Self-citationPapadopoulos, V., & Aghababyan, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00218-1
Дорош, О., Левінтанус, В., Feskova, A., Feskov, O. M., Feskova, I., Konoplia, L., & Герасименко, Л. В. (2026) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2026.2.09
(1991) · Europe PMC (PubMed Central) · Cited by 164
Metadata
- Authors
- Rodrigues, N. R., Dunham, I., Yu, C. Y., Carroll, M. C., Porter, R. R., & Campbell, R. D.
- Venue
- The EMBO Journal
- Published
- 1987-06-01
- Volume
- 6
- Issue
- 6
- Pages
- 1653-1661
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC553538
- OpenAlex
- W1568019658
- Semantic Scholar
- c409c6a71e5d6a8da1d3fca733b677457cb6f3e0
- Cited by
- 182
- References
- 48
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 6 · 2013: 2 · 2012: 4
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, salt-wasting congenital adrenal hyperplasia, adrenal steroidogenesis, gene cloning, nucleotide sequence comparison, amino acid substitutions, pseudogenes, microsomal enzymes
- MeSH terms
- Adrenal Hyperplasia, Congenital, Amino Acid Sequence, Base Sequence, Cell Line, Cloning, Molecular, Cosmids, DNA, DNA Restriction Enzymes, Genes, Genes, MHC Class II, HLA Antigens, Humans, Major Histocompatibility Complex, Plasmids, Steroid Hydroxylases, Steroid 21-Hydroxylase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review